Home›Stock Screener›Fermenta Biotech

Fermenta Biotech Share Price Today | Stock Price & Fermenta Biotech Share Screener

FERMENTA Pharmaceuticals & Biotechnology
Live Share Price NSE
₹462.30
▲ 5.90 (1.29%)
2026-11-19 00:00:00
Live Share Price BSE
₹464.40
▲ 8.80 (1.93%)
2026-11-19 00:00:00

As of November 19, 2026, the live Fermenta Biotech share price (NSE: FERMENTA) is ₹462.30 on NSE and ₹464.40 on BSE, up 1.29% from the previous close, with shares trading between ₹452.00 and ₹468.95 in today's trading session, and a 52-week range of ₹281.00–₹569.45. Track FERMENTA company valuation to gauge the company's total market size. Use the Fermenta Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Fermenta Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹136 and net income of ₹19, with EBITDA of ₹34, an operating margin of 16.0% and a profit margin of 14.0%.

Fermenta Biotech Market Cap ₹1,343.23 Cr.
FERMENTA P/E Ratio (TTM) 27.60
Fermenta Biotech P/B Ratio 3.27
EPS (TTM) ₹24.70
Dividend Yield 0.81%
Debt to Equity 0.30
FERMENTA 52 Week High ₹569.45
Fermenta Biotech 52 Week Low ₹281.00
Operating Margin 16.00%
Profit Margin 13.97%
FERMENTA Revenue (TTM) ₹136.00
EBITDA ₹34.00
Net Income ₹19.00
Total Assets ₹648.00
Total Equity ₹401.00

Fermenta Biotech Share Price Chart

Track the current stock price of Fermenta Biotech with an interactive chart. Analyse FERMENTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Fermenta Biotech stock quote in one place.

The quote of ₹462.30 sits between the 52-week low of ₹281.00 and the 52-week high of ₹569.45, and the latest session moved 1.29% from the previous close.

Fermenta Biotech Company Profile - Fundamental Screener

Screen Fermenta Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FERMENTA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE225B01021.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE225B01021

Fermenta Biotech Balance Sheet Screener

Screen FERMENTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹648, up from ₹615 in 2025.

Latest statistics put total assets at ₹648 and shareholder funds at ₹401, with a leverage ratio of 0.30.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 648 615 548 637 707 687 614 551 387 308
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 220 227 269 267 299 263 200 178 177 172

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 39 44 89 115 128 117 110 145 146 49
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 401 359 285 313 372 360 309 251 137 173
Share Capital 14 15 14 14 14 14 14 5 2 2
Reserves & Surplus 392 348 274 301 358 346 295 246 124 142

Fermenta Biotech Income Statement Screener - Profit & Revenue Analysis

Screen Fermenta Biotech income statement and profit fundamentals. Analyze FERMENTA quarterly results. Fermenta Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹136 and net profit was ₹19, equal to earnings per unit of ₹6.66, at an operating margin of 16%.

In that period expenses were ₹102, interest cost ₹3 and tax ₹8. The next period listed, 2026-Jun, shows revenue of ₹126 and net profit of ₹10.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec

Revenue and Expenses

Revenue 136 126 136 144 145 136 141 103 81 98 159 106 85 59 102
Expenses 102 104 113 103 108 104 115 92 77 76 103 95 72 78 74

Operating Costs and Margins

EBITDA 34 22 23 41 37 32 26 11 4 22 56 11 13 -19 28
Operating Profit % 16.00% 15.00% 15.00% 26.00% 21.00% 20.00% 17.00% 6.00% 1.00% 20.00% 34.00% 10.00% 13.00% -38.00% 25.00%
Depreciation 5 5 5 6 6 5 5 7 6 6 6 6 6 6 6
Interest 3 3 4 3 3 3 3 3 3 4 4 6 5 4 5

Profit and Earnings

Profit Before Tax 26 15 14 32 28 24 18 1 -6 12 45 -1 2 -29 16
Tax 8 5 5 -1 7 6 6 8 0 1 8 4 0 0 6
Net Profit 19 10 9 33 22 18 12 -7 -6 11 38 -5 2 -29 10
EPS 6.66 3.40 3.41 11.79 7.49 6.20 4.36 -2.41 -2.01 3.94 12.71 -1.42 0.64 -7.32 3.41

Fermenta Biotech Cash Flow Screener - Liquidity Fundamentals

Screen FERMENTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹93, and net cash flow was an inflow of ₹8.

Over the same period, investing activities used ₹43 and financing activities used ₹42.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 93 41 105 116 43 63 35 90 59 2
Investing Activities -43 0 -16 -55 -26 -41 -44 -97 -101 7

Financing and Net Cash

Financing Activities -42 -51 -91 -41 -22 -1 -48 12 89 -12
Net Cash Flow 8 -10 -1 19 -4 21 -57 6 47 -4

Fermenta Biotech Shareholding Pattern Screener

See Fermenta Biotech shareholding pattern with promoter, FII, and DII holdings. Check Fermenta Biotech promoter holding and ownership changes for FERMENTA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 64.09%, foreign institutions 0.02%, domestic institutions 0.00% and the public 28.80%, spread across 13,661 shareholders.

The shareholder count was 13,661 in 2026-Mar, compared with 14,131 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Jul 2026-Aug 2026-Sept 2025-Mar 2025-Jun 2025-Sept

Promoter Holding

Promoter Holding 64.09% 64.09% 64.09% 64.09% 60.12% 64.09% 64.09% 64.09%

Institutional Investors

FII Holding 0.02% 0.13% 0.35% 0.37% 1.05% 0.02% 0.02% 0.02%
DII Holding 0.00% 0.04% 0.04% 0.04% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.80% 28.33% 28.42% 28.46% 31.09% 30.38% 29.60% 29.76%
Other Holding 7.09% 7.42% 7.11% 7.04% 7.73% 5.51% 6.29% 6.12%
Shareholder Count 13,661 14,131 14,991 14,777 16,084 12,930 12,845 13,760

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Fermenta Biotech. Fermenta Biotech dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.75 per unit for 2026-March, a yield of 0.81%, compared with ₹2.50 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.75, ₹2.50 and ₹1.25 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹3.75 0.81%
2025-March ₹2.50 0.78%
2024-March ₹1.25 0.46%
2023-March ₹1.25 0.83%
2022-March ₹1.25 1.12%
2021-March ₹2.50 1.22%
2020-March ₹5.00 2.00%
2019-March ₹1.25 0.59%
2018-March ₹2.50 0.91%
2017-March ₹2.50 1.05%

Fermenta Biotech Stock Index Membership - Nifty & Sensex

See which indices include Fermenta Biotech stock. Check FERMENTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Fermenta Biotech is not part of any tracked indices.
Only major market indices are tracked in our system.

Fermenta Biotech Market Events Screener - Corporate Actions

Get Fermenta Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Fermenta Biotech stock events that may affect FERMENTA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 5, 2026, with a record date of November 5, 2026.

It is followed by Quarterly Result Announcement dated August 11, 2026 and Annual General Meeting dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-05 2026-11-05 Quarterly Result Announcement NA -0.91%
2026-08-11 2026-08-11 Quarterly Result Announcement NA 7.19%
2026-08-11 2026-08-11 Annual General Meeting NA 80.22%
2026-08-05 2026-08-05 Dividend ₹ 3.75 /share 79.65%
2026-05-26 2026-05-26 Quarterly Result Announcement NA 5.55%
2026-02-09 2026-02-09 Quarterly Result Announcement NA -0.20%
2025-11-11 2025-11-11 Quarterly Result Announcement NA 3.74%
2025-08-12 2025-08-12 Annual General Meeting NA 17.70%
2025-08-12 2025-08-12 Quarterly Result Announcement NA -2.81%
2025-08-06 2025-08-06 Dividend ₹ 2.50 /share 22.43%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -1.97%
2025-02-11 2025-02-11 Quarterly Result Announcement NA 11.80%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -5.12%
2024-08-12 2024-08-12 Annual General Meeting NA 52.13%
2024-08-06 2024-08-06 Dividend ₹ 1.25 /share 46.02%

Fermenta Biotech Competitors Screener - Peer Stocks Comparison

Screen FERMENTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,036 40.80 61,674 12.69% 11,565 60.77
Divis Laboratories 293,316 87.70 11,067 13.95% 2,568 65.94
Torrent Pharmaceuticals 175,376 84.70 13,886 20.34% 2,138 42.26
Laurus Labs 125,488 94.90 6,868 22.01% 890 55.82
Zydus Life Science 119,900 27.90 27,658 17.64% 5,026 55.22
Dr Reddys Laboratories 116,705 42.00 35,059 3.90% 4,158 73.09
Cipla 114,474 39.20 29,045 2.24% 3,870 62.07
Mankind Pharma 108,424 47.50 14,636 14.85% 1,938 62.66
Aurobindo Pharma 103,355 25.90 34,145 5.56% 3,503 60.69
Lupin 90,173 17.10 29,039 26.75% 5,356 44.73

Fermenta Biotech Company Announcements - News & Reports Screener

Screen FERMENTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 6, 2026.

The next most recent announcements are dated November 6, 2026 and November 5, 2026.

Date Update Actions
2026-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-06 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-11-05 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-05 Intimation Regarding The BoardS Decision To Close The CompanyS Wholly-Owned Subsidiary - Fermenta Biotech (UK) Limited. -
2026-11-05 Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results For Quarter Ended September 30 2026. -
2026-11-05 Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended September 30 2026. -
2026-10-29 Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For Quarter And Half Year Ended September 30 2026. -
2026-10-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-09 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-10-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-30 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-29 Closure of Trading Window -
2026-09-24 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-21 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-16 Dispatch Of Letters To Shareholders Regarding Transfer Of Equity Shares Of The Company To The Investor Education And Protection Fund (IEPF) Account. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹462.30, within a 52-week range of ₹281.00 to ₹569.45. The P/E ratio is 27.60 and the P/B ratio is 3.27, with earnings per unit of ₹24.70. Market capitalisation stands at ₹1,343.23 Cr and the dividend yield is 0.81%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 21, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.